Seroprevalence of Toxoplasma gondii in Pregnant Women and Bioassay of IgM Positive Cases in Zanjan, Northwest of Iran
,
Abstract
Background: The aim of this study was to determine the Toxoplasma antibodies in pregnant women in Zanjan, by ELISA method.
Methods: Blood samples were taken from 500 pregnant women referred to the health centers of Zanjan City, North West Iran, IgM and IgG titers were primarily evaluated. The collected data were analyzed with SPSS 11.5 using Chi-Square test.
Results: Anti Toxoplasma IgM and IgG were positive in 1.4% and 37.2% respectively. Seropositive subjects were more frequently seen in those with >30 years old compared to younger women (<20 years old). No significant relationship was found between the seroprevalence of T. gondii infection and level of education, residence area, history of abortion and gestational age.
Conclusion: The rate of IgM positive was low; however, a large number of the studied population were IgG positive, indicative of having a latent infection due to the past exposure to Toxoplasma parasite in this region.
Krick JA, Remington JS.Toxoplasmosis in the adult: an overview. N Engl J Med. 1978; 298: 550-3.
Dubey JP, Beattie CP. Toxoplasmosis of animal and man. CRC Press, Boca Raton, FL, 1988: 1-220.
Saeedi M, Veghari GR, Marjani A. Seroepidemiologic evaluation of anti-Toxoplasma antibodies among women in North of Iran. Pak J Biol Sci. 2007; 10: 2359-62.
Youssefi MR, Sefidgar AA, Mostafazadeh A, Omran SM. Serologic evaluation of toxoplasmosis in matrimonial women in Babol Iran. Pak J Biol Sci. 2007; 10(9):1550-2.
SharifM, Ajami A,Daryani A, Ziaei H, Khalilian A. Serological survey of toxoplasmosis in women referred to medical health laboratory before marriage northern Iran 2003-2004. Int JMolMed Adv Sci. 2006; 2(2): 134-7.
Fallah M, Rabiee S, Matini M, Taherkhani H. Seroepidemiology of toxoplasmosis in primigravida women in Hamadan Islamic Republic of Iran 2004. East Mediterr Health J. 2008; 14:163–71.
Hashemi HJ, Saraei M. Seroprevalence of Toxoplasma gondii in unmarried women in Qazvin Islamic Republic of Iran. East Mediterr Health J. 2010; 16(1): 24-8.
Fallah M, Rabiee S, Matini M, Taherkhani H. Seroepidemiology of Toxoplasma infection in women aged 15–45 years in Hamadan west of Iran. JResHealth Sci. 2003; 3(1): 9–12.
Mansoori Fl. Seroepidemiology of toxoplasmosis in Kermanshah province west of Iran 2002.Behboud. 2004; 7(2): 12-9.
Abdi J, Shojaee S, Mirzaee A, Keshavarz H. Seroprevalence of Toxoplasmosis in Pregnant Women in Ilam Province Iran. Iranian J Parasitol. 2008; 3(2): 34-7.
SharifiMood B, Hashemi ShahriM, SalehiM, NaderiM,Naser Poor T. Seroepidemiology of Toxoplasma Infection in the Pregnant Women in Zahedan, Southeast of Iran. J Res Health Sci. 2006; 6(1): 1-3.
Fouladvand M, Barazesh A, Naeimi B, Zandi K, Tajbakhsh S. Seroprevalence of toxoplasmosis in high school girls in Bushehr city South-west of Iran 2009. Afr J Microbiol Res. 2010; 4 (11): 1117-21.
Foladvand M, Jaafary SM. Prevalence of antibodies to Toxoplasma gondii in pregnant women of Bushehr. Iranian South Med J. 3(2): 113-116.
ManouchehriNaeini K,Deris F, ZebardastN. The immunity status of the rural pregnant women in Chaharmahal and Bakhtyari province against Toxoplasma infection 2001–2002. J Shahrekord Med Sci. 2004; 6(3):63–72.
Keshavarz valian H, Nateghpour M, Zibaee M. Seroepidemiology of toxoplasmosis in Karaj Iran in 1998. Iranian J Publ Health. 1998; 27(3-4): 73-8.
Keshavarz Valian H, Mamishi S, Daneshvar H. Prevalevce of toxplasmosis in hospitalized patient of Kerman hospitals Iran. J Med Sci Kerman. 2000; 7(2): 126-39.
Arbabi M, Talari SA. Seroprevalence of Toxoplasma infection in pregnant women in Kashan Iran. Feiz J. 2001; 22: 28-38.
Ataeian A, Tadayon P. Prevalence of Toxoplasma gondii antibodies in women of Zanjan Hakim Hidajy hospital. J Zanjan Med Sci. 2000; 8(32):4-11.
Varella IS, Wagner MB, Darela AC, Nunes LM, MullerRW. Seroprevalence of toxoplasmosis in pregnant women. J Pediatr (Rio J). 2003; 79(1): 69-74.
Nash JQ, Chissel S, Jones J, Warburton F, Verlander NQ. Risk factors for toxoplasmosis in pregnant women in Kent, UnitedKingdom. Epidemiol Infect. 2005; 133(3): 475-83.
Jones JL, Kruszon-Moran D, Wilson M, McQuillan G, Navin T, McAuley JB. Toxoplasma gondii infection in the United States: seroprevalence and risk factors. Am J Epidemiol. 2001; 154(4): 357-65.
Ertug S, Okyay P, TurkmenM, Yuksel H. Seroprevalence and risk factors for toxoplasma infection among pregnant women in Aydin province, Turkey. BMC Public Health. 2005; 5: 66-71.
Mostafavia SN, Ataei B, Nokhodian Z, Yaran M, Babak A. Seroepidemiology of Toxoplasma gondii infection in Isfahan province, central Iran: A population based study. J ResMed Sci. 2011; 16 (4): 496-501.
LebechM, Larsen SO, Petersen E. Prevalence, incidence and geographical distribution of Toxoplasma gondii antibodies in pregnant women inDenmark. Scand J InfectDis. 1993; 25(6): 751-6.
Ades AE, Parker S, Gilbert R, Tookey PA, Berry T, Hjelm M, Wilcox AH, Cubitt D, Peckham CS. Maternal prevalence of Toxoplasma antibody based on anonymous neonatal serosurvey: a geographical analysis. Epidemiol Infect. 1993; 110(1): 127-33.
Fallahi Sh, Badparva E, Mohammadi M, Ebrahimzadeh F, Pournia Y. Ser-oepidemiological Study of Toxoplasma gondii in Women Referred to Khorramabad Lab-oratory of Health Center for Medical Examination before Marriage, Lorestan Province, Iran, 2007. Asian J Biol Sci. 2009; 2 (3): 88-94.
| Files | ||
| Issue | Vol 7 No 2 (2012) | |
| Section | Articles | |
| Keywords | ||
| Toxoplasma gondii Prevalence Pregnant women ELISA Iran | ||
| Rights and permissions | |
|
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
